AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 155 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $97 | -72.6% | 22,986 | -79.9% | 0.01% | -77.1% |
| Q2 2023 | $354 | +216.1% | 114,251 | +41.9% | 0.04% | +218.2% |
| Q1 2023 | $112 | -67.8% | 80,519 | -54.0% | 0.01% | -74.4% |
| Q4 2022 | $348 | -99.9% | 175,049 | +15.3% | 0.04% | -40.3% |
| Q2 2022 | $483,000 | +7.3% | 151,865 | +40.6% | 0.07% | +20.0% |
| Q1 2022 | $450,000 | +181.2% | 107,974 | +223.3% | 0.06% | +200.0% |
| Q4 2021 | $160,000 | -71.9% | 33,402 | -70.0% | 0.02% | -68.8% |
| Q2 2021 | $569,000 | +240.7% | 111,200 | +347.2% | 0.06% | +128.6% |
| Q1 2021 | $167,000 | -7.7% | 24,867 | -37.1% | 0.03% | -6.7% |
| Q4 2020 | $181,000 | -13.4% | 39,552 | -26.6% | 0.03% | -14.3% |
| Q3 2020 | $209,000 | -12.2% | 53,864 | +7.9% | 0.04% | -73.7% |
| Q2 2020 | $238,000 | -30.4% | 49,901 | -49.2% | 0.13% | +54.7% |
| Q1 2020 | $342,000 | -7.1% | 98,239 | +91.6% | 0.09% | +109.8% |
| Q2 2019 | $368,000 | +56.6% | 51,264 | +195.6% | 0.04% | +51.9% |
| Q4 2018 | $235,000 | – | 17,343 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $83,503,000 | 7.34% |
| Eversept Partners, LP | 2,656,208 | $10,306,087 | 2.29% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $62,908,000 | 1.13% |
| Prosight Management, LP | 512,659 | $1,989,000 | 0.95% |
| THB ASSET MANAGEMENT | 833,104 | $3,232,000 | 0.90% |
| GLOBEFLEX CAPITAL L P | 251,696 | $977,000 | 0.26% |
| XTX MARKETS LLC | 10,243 | $40,000 | 0.19% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 102,000 | $396,000 | 0.10% |
| PA Capital LLC | 33,874 | $132,000 | 0.09% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 60,900 | $236,000 | 0.07% |